Changi General Hospital

Running trials

• Not yet recruiting

  Concurrent Trials on Nature-Based Therapy for Inpatients in Dementia and Rehabilitation Medicine Wards

  NCT07059390· Source

• Not yet recruiting

  Mailed FIT-Based Outreach Interventions

  NCT07852793· Source

• Not yet recruiting

  Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer

  NCT07111130· Source

• Recruiting

  Feasibility, Safety and Efficacy of a Predominantly Plant-based Diet in an Asian Population With Chronic Kidney Disease

  NCT07544524· Source

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Source

• Recruiting

  Left Bundle Branch Area Pacing (LBBAP) PMCF Study

  NCT07217392· Source

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Source

• Recruiting

  OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities

  NCT06890169· Source

• Active, not recruiting

  ASCEND CSP IDE Study

  NCT06830746· Source

• Recruiting

  Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)

  NCT06965062· Source

• Recruiting

  Endoscopic Conversion of Sleeve Gastrectomy to Single Anastomosis Sleeve-ileal Bypass (SASI) for Gastroesophageal Reflux (GERD), Primary and Secondary Non-responder.

  NCT06757296· Source

• Recruiting

  Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors

  NCT06549673· Source

• Recruiting

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  NCT06632457· Phase 3· Source

• Recruiting

  AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis

  NCT06709209· Source

• Recruiting

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· Phase 3· Source

• Active, not recruiting

  Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

  NCT06492291· Phase 3· Source

• Recruiting

  Addressing Medication Non-adherence in Patients With Poorly Controlled Hypertension Using Urine Mass Spectrometry

  NCT06938633· Source

• Recruiting

  Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat

  NCT06569589· Source

• Enrolling by invitation

  Model Development and Temporal Validation of the Predictive Factors for Return to Work After Stroke Rehabilitation

  NCT06842420· Source

• Recruiting

  Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

  NCT06051617· Phase 3· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

  NCT05797610· Phase 3· Source

• Recruiting

  Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma

  NCT05516628· Phase 2· Source

• Active, not recruiting

  The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD

  NCT05374291· Phase 3· Source

• Recruiting

  SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)

  NCT05724264· Source

• Active, not recruiting

  Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma

  NCT05148572· Source

• Active, not recruiting

  Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)

  NCT04965259· Source

• Active, not recruiting

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· Phase 3· Source

• Active, not recruiting

  A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy

  NCT03675308· Phase 3· Source

• Active, not recruiting

  A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)

  NCT03671148· Phase 3· Source

• Active, not recruiting

  Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices

  NCT03366545· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure5 recruiting
• Fatty liver disease (MASLD/MASH)3 recruiting
• Liver and biliary tract cancer2 recruiting
• Obesity2 recruiting
• Stroke2 recruiting
• Type 2 diabetes2 recruiting
• Alzheimer disease1 recruiting
• Atrial fibrillation1 recruiting
• Chronic kidney disease1 recruiting
• Colorectal cancer1 recruiting
• Heart failure1 recruiting
• Lung cancer1 recruiting
• Primary biliary cholangitis1 recruiting
• Type 1 diabetes1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Body Composition, Frailty, and Function in Rehabilitation

  NCT06527742· Source

• Completed

  A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

  NCT06522997· Phase 2· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  NCT06430801· Phase 3· Source

• Completed

  A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH)

  NCT05952869· Phase 3· Source

• Completed

  MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits

  NCT05289947· Phase 2· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Source

• Completed

  Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations

  NCT05417906· Phase 2· Source

• Completed

  A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

  NCT05093933· Phase 3· Source

• Completed

  Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT05016882· Phase 2· Source

• Completed

  Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)

  NCT04846881· Phase 3· Source

• Completed

  Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB)

  NCT04891770· Phase 2· Source

• Terminated

  PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE

  NCT04601467· Phase 2· Source

• Completed

  Assessing the Utility of Peak Inspiratory Flow as a Predictor for COPD Exacerbations

  NCT04360226· Source

• Completed

  Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global

  NCT04236609· Source

• Completed

  Mid-Q Response Study

  NCT04180696· Source

• Completed

  11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours

  NCT06100367· Phase 2/3· Source

• Completed

  A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)

  NCT03607422· Phase 3· Source

• Completed

  Confirm Rx Insertable Cardiac Monitor SMART Registry

  NCT03505801· Source

Trial sites

• Changi General Hospital39 trials
• Changi General Hospital (CGH)1 trial
• Changi General Hospital /ID# 2052231 trial
• Changi General Hospital /ID# 2089651 trial
• Changi General Hospital /ID# 2089661 trial
• Changi General Hospital, Singapore1 trial
• Changi General Hospital (Site 3211)2 trials
• Changi General Hospital (Site 3356)1 trial
• Changi General Hospital (Site 6203)1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Primary biliary cholangitis9 works · 1 trials